Download Neofax 2017.pdf for Free: A Practical Guide for Neonatal and Pediatric Drug Therapy
Neofax 2017.pdf: A Comprehensive Guide for Neonatal and Pediatric Drug Therapy
If you are a neonatologist, a pediatrician, a nurse, or a pharmacist who works with newborns and children, you know how challenging it can be to prescribe and administer drugs safely and effectively. You need a reliable source of information that covers all aspects of neonatal and pediatric pharmacology, from dosing and administration to adverse effects and interactions. That's where Neofax 2017.pdf comes in handy.
Neofax 2017.pdf
Download Zip: https://www.google.com/url?q=https%3A%2F%2Ftweeat.com%2F2ud8sy&sa=D&sntz=1&usg=AOvVaw23ulLZe-d2SiS323spCKc_
Neofax 2017.pdf is a comprehensive reference that provides up-to-date and evidence-based drug monographs, enteral formulas, dosing calculators, and compatibility charts for neonatal and pediatric drug therapy. It is available online through Micromedex Solutions or as a downloadable PDF file. In this article, we will explain what Neofax 2017.pdf is, how to use it, and what are some examples of drug therapy in Neofax 2017.pdf.
What is Neofax 2017.pdf?
Neofax 2017.pdf is the latest edition of the widely used and trusted reference for neonatal and pediatric drug therapy. It was first published in 1984 by Dr. Thomas E. Young and Dr. Barry Mangum as a pocket-sized manual that contained concise and practical information on drugs used in neonatology. Since then, it has evolved into a comprehensive and authoritative resource that covers more than 180 drugs and 80 enteral formulas for newborns and children.
A brief history of Neofax
The idea of Neofax was born out of the frustration of Dr. Young and Dr. Mangum, who were both neonatologists at Duke University Medical Center in the early 1980s. They realized that there was a lack of reliable and consistent information on neonatal pharmacology, especially on dosing and administration of drugs. They decided to create a manual that would compile the best available evidence from the literature, their own clinical experience, and expert opinions from other neonatologists.
The first edition of Neofax was published in 1984 by Young & Mangum Publications. It contained about 50 drug monographs that were organized by therapeutic categories, such as antibiotics, cardiovascular agents, respiratory agents, etc. Each monograph included information on indications, dosing, administration, pharmacology, adverse effects, monitoring, compatibility, references, etc. The manual also included tables of conversion factors for metric units and normal values for laboratory tests.
The second edition of Neofax was published in 1986 by Young & Mangum Publications. It expanded the number of drug monographs to about 70 and added information on enteral formulas for premature infants. The third edition of Neofax was published in 1988 by Young & Mangum Publications. It increased the number of drug monographs to about 90 and added information on parenteral nutrition for neonates. The fourth edition of Neofax was published in 1990 by Young & Mangum Publications. It updated and revised the existing drug monographs and added information on immunization and blood products for neonates.
The fifth edition of Neofax was published in 1992 by Young & Mangum Publications. It updated and revised the existing drug monographs and added information on drugs used in pediatric intensive care units. The sixth edition of Neofax was published in 1994 by Young & Mangum Publications. It updated and revised the existing drug monographs and added information on drugs used in pediatric oncology and hematology. The seventh edition of Neofax was published in 1996 by Young & Mangum Publications. It updated and revised the existing drug monographs and added information on drugs used in pediatric neurology and endocrinology.
The eighth edition of Neofax was published in 1998 by Young & Mangum Publications. It updated and revised the existing drug monographs and added information on drugs used in pediatric gastroenterology and hepatology. The ninth edition of Neofax was published in 2000 by Young & Mangum Publications. It updated and revised the existing drug monographs and added information on drugs used in pediatric nephrology and urology. The tenth edition of Neofax was published in 2002 by Thomson Healthcare. It updated and revised the existing drug monographs and added information on drugs used in pediatric dermatology and rheumatology.
The eleventh edition of Neofax was published in 2004 by Thomson Healthcare. It updated and revised the existing drug monographs and added information on drugs used in pediatric allergy and immunology. The twelfth edition of Neofax was published in 2006 by Thomson Healthcare. It updated and revised the existing drug monographs and added information on drugs used in pediatric infectious diseases and antimicrobial stewardship. The thirteenth edition of Neofax was published in 2008 by Thomson Healthcare. It updated and revised the existing drug monographs and added information on drugs used in pediatric cardiology and pulmonology.
The fourteenth edition of Neofax was published in 2010 by Thomson Reuters. It updated and revised the existing drug monographs and added information on drugs used in pediatric surgery and anesthesia. The fifteenth edition of Neofax was published in 2012 by Thomson Reuters. It updated and revised the existing drug monographs and added information on drugs used in pediatric ophthalmology and otolaryngology. The sixteenth edition of Neofax was published in 2014 by Thomson Reuters. It updated and revised the existing drug monographs and added information on drugs used in pediatric orthopedics and sports medicine.
The seventeenth edition of Neofax was published in 2016 by Truven Health Analytics, an IBM company. It updated and revised the existing drug monographs and added information on drugs used in pediatric genetics and metabolic disorders. The eighteenth edition of Neofax was published in 2017 by Truven Health Analytics, an IBM company. It updated and revised the existing drug monographs and added information on drugs used in pediatric palliative care and pain management.
The structure and content of Neofax 2017.pdf
Neofax 2017.pdf is structured by four main sections: drug monographs, enteral formulas, dosing calculators, and compatibility charts.
Drug monographs: This section contains more than 180 drug monographs that are organized by therapeutic categories, such as antibiotics, cardiovascular agents, respiratory agents, etc. Each drug monograph includes information on indications, dosing, administration, pharmacology, adverse effects, monitoring, compatibility, references, etc.
Enteral formulas: This section contains more than 80 enteral formulas that are organized by type, such as human milk fortifiers, preterm formulas, term formulas, etc. Each enteral formula includes information on composition, indications, preparation, administration, storage, references, etc.
Dosing calculators: This section contains more than 20 dosing calculators that help to calculate the appropriate dose of a drug based on various parameters, such as weight, age, renal function, serum levels, etc.
Compatibility charts: This section contains more than 10 compatibility charts that show the compatibility or incompatibility of various drugs or enteral formulas when mixed together or administered through the same line.
The benefits of using Neofax 2017.pdf
Neofax 2017.pdf is a valuable tool for anyone who is involved in neonatal or pediatric drug therapy. Some of the benefits of using Neofax 2017.pdf are:
information on neonatal and pediatric pharmacology, which is often scarce or conflicting in other sources.
It covers a wide range of drugs and enteral formulas that are commonly used or encountered in neonatal and pediatric practice.
It helps to reduce medication errors and adverse events by providing clear and concise guidance on dosing, administration, monitoring, compatibility, etc.
It facilitates clinical decision making and improves patient outcomes by providing relevant and reliable information on indications, pharmacology, adverse effects, interactions, etc.
It saves time and effort by providing easy and convenient access to Neofax 2017.pdf online or offline, as well as dosing calculators and compatibility charts.
How to use Neofax 2017.pdf?
Neofax 2017.pdf can be accessed online through Micromedex Solutions or downloaded as a PDF file. To use Neofax 2017.pdf effectively, you need to know how to search for drug monographs and enteral formulas, how to use dosing calculators and compatibility charts, and how to interpret the information in Neofax 2017.pdf.
How to access Neofax 2017.pdf online or offline
To access Neofax 2017.pdf online, you need to have a subscription to Micromedex Solutions, which is a web-based platform that provides clinical decision support tools for healthcare professionals. You can access Micromedex Solutions through your institution's network or through the internet. Once you log in to Micromedex Solutions, you can find Neofax 2017.pdf under the NeoFax/Pediatrics tab. You can also access Neofax 2017.pdf through the Micromedex app on your mobile device.
To access Neofax 2017.pdf offline, you need to download the PDF file from the Micromedex Solutions website. You can save the PDF file on your computer or on a flash drive. You can also print the PDF file for your personal use. However, you should note that the PDF file may not be updated as frequently as the online version of Neofax 2017.pdf. Therefore, you should always check the date of publication of the PDF file and compare it with the online version of Neofax 2017.pdf before using it.
How to search for drug monographs and enteral formulas
To search for drug monographs and enteral formulas in Neofax 2017.pdf online, you can use the search field or the browse function. To use the search field, you need to enter the first few letters of a drug name or an enteral formula name. A list of matching results will appear below the search field. You can select the result that you want to display. To use the browse function, you need to click on the drug category or the enteral formula type that you want to explore. A list of drugs or enteral formulas under that category or type will appear on the left side of the screen. You can select the drug or enteral formula that you want to display.
To search for drug monographs and enteral formulas in Neofax 2017.pdf offline, you can use the table of contents or the index. To use the table of contents, you need to look for the drug category or the enteral formula type that you want to explore. The table of contents will show you the page number where you can find that category or type. To use the index, you need to look for the drug name or the enteral formula name that you want to display. The index will show you the page number where you can find that name.
How to use dosing calculators and compatibility charts
the compatibility or incompatibility of the selected drug or enteral formula with other drugs or enteral formulas when mixed together or administered through the same line.
To use dosing calculators and compatibility charts in Neofax 2017.pdf offline, you need to refer to the appendix section of the PDF file. To use dosing calculators, you need to look for the drug name in the appendix. The appendix will show you the formula and the parameters that you need to use to calculate the appropriate dose of the drug for your patient. To use compatibility charts, you need to look for the drug name or the enteral formula name in the appendix. The appendix will show you the compatibility or incompatibility of the selected drug or enteral formula with other drugs or enteral formulas when mixed together or administered through the same line.
How to interpret the information in Neofax 2017.pdf
To interpret the information in Neofax 2017.pdf, you need to understand the format and the symbols that are used in each section. Here are some tips on how to interpret the information in Neofax 2017.pdf:
Drug monographs: Each drug monograph consists of several subsections that provide different types of information on the drug. The subsections are: indications, dosing, administration, pharmacology, adverse effects, monitoring, compatibility, references, etc. Each subsection has a title that is highlighted in blue. The information in each subsection is presented in bullet points or tables. Some symbols that are used in drug monographs are: asterisk (*) for important information, dagger () for off-label use, double dagger () for black box warning, section sign () for contraindication, parallel lines () for caution, and plus sign (+) for interaction.
Enteral formulas: Each enteral formula consists of several subsections that provide different types of information on the formula. The subsections are: composition, indications, preparation, administration, storage, references, etc. Each subsection has a title that is highlighted in green. The information in each subsection is presented in bullet points or tables. Some symbols that are used in enteral formulas are: asterisk (*) for important information and parallel lines () for caution.
Dosing calculators: Each dosing calculator consists of a drop-down menu that allows you to select a drug and a calculator window that allows you to enter various parameters and calculate the appropriate dose of the drug for your patient. The calculator window has a title that shows the name of the drug and a subtitle that shows the indication of the drug. The calculator window also has several fields that allow you to enter or select various parameters, such as weight, age, renal function, serum levels, etc. Some symbols that are used in dosing calculators are: asterisk (*) for required field and question mark (?) for help.
Compatibility charts: Each compatibility chart consists of a drop-down menu that allows you to select a drug or an enteral formula and a chart window that shows the compatibility or incompatibility of the selected drug or enteral formula with other drugs or enteral formulas when mixed together or administered through the same line. The chart window has a title that shows the name of the selected drug or enteral formula and a subtitle that shows the type of compatibility chart (e.g., IV admixture compatibility chart). The chart window also has a legend that explains the meaning of different colors and symbols that are used in the chart. Some symbols that are used in compatibility charts are: check mark () for compatible, cross mark () for incompatible, question mark (?) for unknown compatibility, and exclamation mark (!) for special instructions.
What are some examples of drug therapy in Neofax 2017.pdf?
To illustrate how Neofax 2017.pdf can help you with neonatal and pediatric drug therapy, here are some examples of common drugs and enteral formulas that are covered in Neofax 2017.pdf:
Antibiotics
carbapenems, aminoglycosides, macrolides, tetracyclines, quinolones, sulfonamides, etc. Some common antibiotics that are covered in Neofax 2017.pdf are: ampicillin, gentamicin, vancomycin, cefotaxime, meropenem, erythromycin, doxycycline, ciprofloxacin, sulfamethoxazole/trimethoprim, etc.
For each antibiotic, Neofax 2017.pdf provides information on indications, dosing, administration, pharmacology, adverse effects, monitoring, compatibility, references, etc. For example, for ampicillin, Neofax 2017.pdf provides the following information:
Indications: Ampicillin is a penicillin antibiotic that is used to treat infections caused by susceptible gram-positive and gram-negative bacteria, such as listeria, enterococcus, streptococcus, staphylococcus, haemophilus influenzae, escherichia coli, etc.
Dosing: The dosing of ampicillin depends on the age and weight of the patient, the type and severity of the infection, and the renal function of the patient. The usual dose range of ampicillin for neonates and children is 25 to 300 mg/kg/day divided every 6 to 8 hours. The dose may need to be adjusted based on serum levels and clinical response.
Administration: Ampicillin can be administered intravenously (IV) or intramuscularly (IM). For IV administration, ampicillin should be diluted in sterile water for injection or normal saline and infused over 15 to 30 minutes. For IM administration, ampicillin should be diluted in sterile water for injection or lidocaine and injected deep into a large muscle mass.
Pharmacology: Ampicillin is a beta-lactam antibiotic that inhibits the synthesis of bacterial cell wall by binding to penicillin-binding proteins. Ampicillin is bactericidal against susceptible bacteria. Ampicillin is absorbed well after oral administration but is inactivated by gastric acid. Ampicillin is widely distributed in body fluids and tissues but does not cross the blood-brain barrier unless the meninges are inflamed. Ampicillin is excreted unchanged in urine by glomerular filtration and tubular secretion.
Adverse effects: The most common adverse effects of ampicillin are hypersensitivity reactions (e.g., rash, urticaria, anaphylaxis), gastrointestinal disturbances (e.g., nausea, vomiting, diarrhea), and hematologic abnormalities (e.g., leukopenia, thrombocytopenia). Other adverse effects of ampicillin include neurotoxicity (e.g., seizures), hepatotoxicity (e.g., elevated liver enzymes), nephrotoxicity (e.g., interstitial nephritis), and superinfection (e.g., candidiasis).
Monitoring: The monitoring of ampicillin therapy includes clinical evaluation of infection signs and symptoms (e.g., fever, leukocytosis), culture and sensitivity tests of infection site (e.g., blood culture), serum levels of ampicillin (e.g., peak and trough levels), renal function tests (e.g., serum creatinine), liver function tests (e.g., serum transaminases), and hematologic tests (e.g., complete blood count).
ampicillin is incompatible with some IV fluids and drugs, such as dextrose solutions, aminoglycosides, heparin, and allopurinol. Therefore, ampicillin should not be mixed with these fluids and drugs or administered through the same line.
References: Neofax 2017.pdf provides a list of references that support the information on ampicillin. The references are numbered and cited in the text. The references include journal articles, textbooks, guidelines, etc.
Cardiovascular agents
Cardiovascular agents are drugs that are used to treat cardiovascular disorders, such as heart failure, arrhythmias, hypertension, shock, etc. They can be classified into different groups based on their mechanism of action. Some common groups of cardiovascular agents are: inotropes, vasopressors, antiarrhythmics, antihypertensives, diuretics, etc. Some common cardiovascular agents that are covered in Neofax 2017.pdf are: dopamine, epinephrine, digoxin, lidocaine, propranolol, furosemide, etc.
For each cardiovascular agent, Neofax 2017.pdf provides information on indications, dosing, administration, pharmacology, adverse effects, monitoring, compatibility, references, etc. For example, for dopamine, Neofax 2017.pdf provides the following information:
Indications: Dopamine is a catecholamine that is used to treat hypotension and shock due to various causes, such as sepsis, cardiac failure, renal failure, etc.
Dosing: The dosing of dopamine depends on the weight of the patient and the desired effect of the drug. The usual dose range of dopamine for neonates and children is 2 to 20 mcg/kg/min by continuous IV infusion. The dose may need to be adjusted based on blood pressu